Northern Trust Corp Tff Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.62 - $1.1 $6,280 - $11,143	10,130 Added 25.9%	49,238 $33,000
Q3 2022 Nov 14, 2022	BUY	$4.61 - $116.0 $20,044 - $504,368	4,348 Added 12.51%	39,108 $159,000
Q2 2022 Aug 12, 2022	BUY	$3.99 - $7.22 $2,146 - $3,884	538 Added 1.57%	34,760 $196,000
Q1 2022 May 13, 2022	SELL	$5.28 - $9.17 $8,379 - $14,552	-1,587 Reduced 4.43%	34,222 $216,000
Q4 2021 Feb 08, 2022	SELL	$6.86 - $9.65 $49,426 - $69,528	-7,205 Reduced 16.75%	35,809 $318,000
Q3 2021 Nov 15, 2021	BUY	$7.21 - $10.49 $107,948 - $157,056	14,972 Added 53.39%	43,014 $332,000
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $55,221 - $88,628	6,512 Added 30.25%	28,042 $269,000
Q1 2021 May 12, 2021	BUY	$12.96 - $19.75 $1,373 - $2,093	106 Added 0.49%	21,530 $292,000
Q4 2020 Feb 11, 2021	SELL	$12.74 - $18.49 $6,497 - $9,429	-510 Reduced 2.33%	21,424 $307,000
Q3 2020 Nov 16, 2020	BUY	$5.86 - $18.47 $128,533 - $405,120	21,934 New	21,934 $405,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.